Jacques Gilles

Jacques Gilles possesses extensive experience in the pharmaceutical and healthcare sectors, currently serving in Strategy and Analytics at Hikma Pharmaceuticals since 2020, focusing on leveraging market intelligence to secure a competitive edge in the generics industry. Previously, Jacques worked at Sandoz from 2018 to 2019, where strategic evaluation and competitive pricing of over 200 generic drugs were prioritized to enhance consumer health and wellness. Prior positions include Northeast Pricing and Contracts Manager at LabCorp from 2012 to 2018, where Jacques managed competitive advantages for a diverse client base, and Senior Pricing Analyst at Quest Diagnostics from 2004 to 2012, where market analysis guided revenue objectives for product launches. Jacques holds a Bachelor's degree in Finance from Rutgers Business School.